tiprankstipranks
Nutra Pharma Corp. (NPHC)
OTHER OTC:NPHC

Nutra Pharma (NPHC) Income Statement

18 Followers

Nutra Pharma Income Statement

Last quarter (Q ), Nutra Pharma's total revenue was $109.20K, an increase of 466.82% from the same quarter last year. In Q, Nutra Pharma's net income was $577.23K. See Nutra Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 247.77K$ 97.73K$ 51.90K$ 104.39K$ 130.60K$ 120.98K
Cost of Revenue
$ 181.24K$ 89.27K$ 36.98K$ 69.68K$ 116.53K$ 26.90K
Gross Profit
$ 66.53K$ 8.47K$ 14.92K$ 34.72K$ 14.06K$ 94.08K
Operating Expense
$ 1.43M$ 2.00M$ 939.86K$ 1.20M$ 1.89M$ 1.48M
Operating Income
$ -1.36M$ -1.99M$ -924.95K$ -1.17M$ -1.88M$ -1.38M
Net Non Operating Interest Income Expense
$ 181.40K$ -11.19M$ -336.17K$ -262.02K$ -590.11K$ -358.65K
Other Income Expense
$ 8.28M$ -78.25K$ -491.94K$ -5.16M$ -1.42M$ -2.29M
Pretax Income
$ 7.11M$ -13.10M$ -769.18K$ -6.59M$ -3.88M$ -4.03M
Tax Provision
-$ -2.78M$ 145.67K$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 7.11M$ -13.10M$ -769.18K$ -6.59M$ -3.88M$ -4.03M
Basic EPS
$ <0.01--$ >-0.01$ >-0.01$ >-0.01
Diluted EPS
$ <0.01--$ >-0.01$ >-0.01$ >-0.01
Basic Average Shares
$ 29.74B$ 7.23B$ 6.61B$ 4.71B$ 3.19B$ 1.05B
Diluted Average Shares
$ 44.89B$ 7.23B$ 6.61B$ 4.71B$ 3.19B$ 1.05B
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 1.61M$ 2.09M$ 976.84K$ 1.27M$ 2.01M$ 1.50M
Net Income From Continuing And Discontinued Operation
$ 7.11M$ -13.10M$ -769.18K$ -6.59M$ -3.88M$ -4.03M
Normalized Income
$ 7.25M--$ -6.61M$ -2.47M$ -1.74M
Interest Expense
$ 328.43K--$ 262.02K$ 590.11K$ 358.65K
EBIT
$ 7.95M$ -12.60M$ -463.86K$ -6.33M$ -3.29M$ -3.67M
EBITDA
$ 8.30M$ -12.22M$ -266.02K$ -6.25M$ -3.29M$ -3.66M
Currency in USD

Nutra Pharma Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis